Synapse - Sergio Giralt

Results (1053)

Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)

Meeting Abstract

Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma

Meeting Abstract

Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/dL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response (RR) at 1 year in light chain (AL) amyloidosis

Meeting Abstract

Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Reduction of opioid use by acupuncture in patients undergoing hematopoietic stem cell transplantation: Secondary analysis of a randomized, sham-controlled trial

Journal Article

Deng, G.; Giralt, S.; Chung, D. J.; Landau, H.; Siman, J.; Li, Q. S.; Lapen, K.; Mao, J. J.
Pain Medicine (2020)

Fulltext@MSK | Save

Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation

Journal Article

Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Slingerland, A. E.; Slingerland, J. B.; more...
New England Journal of Medicine (2020)

Fulltext@MSK | Save

Phase I study of selinexor, ixazomib, and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma

Research Letter

Salcedo, M.; Lendvai, N.; Mastey, D.; Schlossman, J.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E.; more...
Clinical Lymphoma, Myeloma and Leukemia (2020)

Fulltext@MSK | Save

Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management

Journal Article

Pennisi, M.; Jain, T.; Santomasso, B. D.; Mead, E.; Wudhikarn, K.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C.; more...
Blood Advances (2020)

Fulltext@MSK | Save

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: A Tri-State Transplant Consortium study